CD34 and acute myeloid leukemia: Similar to results in AML lines, the average abundance of RNF5 protein was significantly higher in PBMCs from AML patients relative to control samples (CD34+ and PBMCs) (Fig. 1b, c, Supplementary Fig. 1c, d).